Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

This is a grant titled, "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)". It encourages research related to creating new methods of screening or therapeutic treatments for severe or potentially fatal conditions discovered through newborn screening. This includes "high priority" genetic conditions that are not currently recommended for screening but may be in the near future.

Such "high priority" conditions are those where early detection and treatment could significantly benefit the child. The aim of this grant is to develop an accurate screening test and demonstrate the advantages of prompt intervention or treatment. These are crucial prerequisites to include a condition in a newborn screening panel. The ultimate goal of this grant is to improve the early detection and treatment of serious conditions in newborns.